Skip to content

D&A at other companies

AMN Healthcare logo
AMN HealthcareAMN
$35.66M-10.5%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$388K+11.5%
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
$19.65M+18.2%
Cencora logo
CencoraCOR

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%
EPS (diluted)-$0.14-600%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%
P/S0.4×+0.1×

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Return on equity-27%-32.7pp
Debt / equity0.0×
Current ratio3.3×+0.3×

Where this comes from

Reported directly by Cross Country Healthcare in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's D&A?
Cross Country Healthcare (CCRN) reported D&A of $3.67M in Q1 2026.
How has Cross Country Healthcare's D&A changed year-over-year?
Cross Country Healthcare's D&A decreased by 23.1% year-over-year, from $4.77M to $3.67M.
What is the long-term trend for Cross Country Healthcare's D&A?
Over 4 years (2021 to 2025), Cross Country Healthcare's D&A has grown at a 14.3% compound annual growth rate (CAGR), from $9.85M to $16.79M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.